Skip to main content
. 2014 Nov 28;15(12):21875–21895. doi: 10.3390/ijms151221875

Table 5.

Effects of samples on gastrointestinal (GI) transit in activated carbon-induced constipation model mice.

Treatment Normal Control Bisacodyl Lactobacillus bulgaricus LF-Suo (×109 CFU/kg b.w.)
0.1 (g) 1.0 (g)
Small intestine length (cm) 47.9 ± 2.6 a 44.6 ± 4.2 a 47.2 ± 2.2 a 46.4 ± 3.2 a 47.0 ± 3.8 a 47.1 ± 2.5 a
Distance traveled (cm) 47.9 ± 2.6 a 18.8 ± 3.2 f 44.7 ± 1.3 b 25.6 ± 2.5 e 34.0 ± 3.1 d 40.3 ± 1.9 c
GI transit (%) 100.0 ± 0.0 a 42.1 ± 5.6 f 94.6 ± 6.7 b 55.2 ± 4.6 e 72.3 ± 6.5 d 85.5 ± 6.3 c

n = 10 ICR mice in each group, bisacodyl: 100 mg/kg b.w.; Lactobacillus bulgaricus (1.0 × 109 CFU/kg b.w.); LF-Suo: Lactobacillus fermentum Suo; a–f Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple range test.